These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 21163900
1. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW. Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900 [Abstract] [Full Text] [Related]
2. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6. Hatch M. Urolithiasis; 2020 Feb; 48(1):1-8. PubMed ID: 31201468 [Abstract] [Full Text] [Related]
3. A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion. Hatch M, Freel RW. Urolithiasis; 2013 Oct; 41(5):379-84. PubMed ID: 23959075 [Abstract] [Full Text] [Related]
4. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria. Klimesova K, Whittamore JM, Hatch M. Urolithiasis; 2015 Apr; 43(2):107-17. PubMed ID: 25269440 [Abstract] [Full Text] [Related]
5. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. Kidney Int; 2006 Feb; 69(4):691-8. PubMed ID: 16518326 [Abstract] [Full Text] [Related]
6. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells. Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H. Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773 [Abstract] [Full Text] [Related]
7. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria. Canales BK, Hatch M. Surg Obes Relat Dis; 2017 Jul 01; 13(7):1152-1157. PubMed ID: 28552742 [Abstract] [Full Text] [Related]
8. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia. Whittamore JM, Stephens CE, Hatch M. Am J Physiol Gastrointest Liver Physiol; 2019 Jan 01; 316(1):G82-G94. PubMed ID: 30383413 [Abstract] [Full Text] [Related]
9. Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. Arvans D, Jung YC, Antonopoulos D, Koval J, Granja I, Bashir M, Karrar E, Roy-Chowdhury J, Musch M, Asplin J, Chang E, Hassan H. J Am Soc Nephrol; 2017 Mar 01; 28(3):876-887. PubMed ID: 27738124 [Abstract] [Full Text] [Related]
10. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene. Li Y, Zheng R, Xu G, Huang Y, Li Y, Li D, Geng H. Am J Physiol Renal Physiol; 2021 Mar 01; 320(3):F475-F484. PubMed ID: 33491567 [Abstract] [Full Text] [Related]
11. Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate. Freel RW, Whittamore JM, Hatch M. Am J Physiol Gastrointest Liver Physiol; 2013 Oct 01; 305(7):G520-7. PubMed ID: 23886857 [Abstract] [Full Text] [Related]
12. Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model. Li X, Ellis ML, Knight J. Appl Environ Microbiol; 2015 Aug 01; 81(15):5048-54. PubMed ID: 25979889 [Abstract] [Full Text] [Related]
13. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition. Verhulst A, Dehmel B, Lindner E, Akerman ME, D'Haese PC. Urolithiasis; 2022 Apr 01; 50(2):119-130. PubMed ID: 35122487 [Abstract] [Full Text] [Related]
14. Oxalobacter formigenes and its potential role in human health. Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS. Appl Environ Microbiol; 2002 Aug 01; 68(8):3841-7. PubMed ID: 12147479 [Abstract] [Full Text] [Related]
15. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB. Am J Kidney Dis; 2011 Sep 01; 58(3):453-5. PubMed ID: 21705122 [Abstract] [Full Text] [Related]
16. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M. BJU Int; 2009 Jan 01; 103(1):18-21. PubMed ID: 19021605 [Abstract] [Full Text] [Related]
17. Gut-kidney axis in oxalate homeostasis. Alshaikh AE, Hassan HA. Curr Opin Nephrol Hypertens; 2021 Mar 01; 30(2):264-274. PubMed ID: 33427760 [Abstract] [Full Text] [Related]
18. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis. Miller AW, Choy D, Penniston KL, Lange D. Kidney Int; 2019 Jul 01; 96(1):180-188. PubMed ID: 31130222 [Abstract] [Full Text] [Related]
19. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H. Urol Res; 2005 Nov 01; 33(5):372-5. PubMed ID: 16284877 [Abstract] [Full Text] [Related]
20. The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Hatch M, Freel RW. Semin Nephrol; 2008 Mar 01; 28(2):143-51. PubMed ID: 18359395 [Abstract] [Full Text] [Related] Page: [Next] [New Search]